investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia
Markus Muschen
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Gregg B Fields
Mechanism and Inhibition of Collagenolytic Activity
Breast
Katerina V Gurova
Modulation of cancer specific transcriptional factors with small molecules
Leukaemia
George A Calin
Protein-coding and non-coding RNA biomarkers for early detection of CLL
Leukaemia
Catherine Ju-Ying Wu
Defining the impact of clonal evolution on chronic lymphocytic leukemia
Leukaemia
Pilar Blancafort
Targeted Epigenetic Silencing of Oncogenic Transcription Factors (PQ18)
Breast
Zhihong Gong
Aberrant DNA methylation patterns of miRNAs and breast cancer racial disparities
Breast
Srikumar P. Chellappan
TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer
Trachea, bronchus and lung
Hui-Kuan Lin
Novel Posttranslational Modification in LKB1 Activation and Cancer Development
Breast
Hallgeir Rui
Prolactin pathways and metastatic progression of ER-positive breast cancer
Breast